Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Enterprise Value (2020 - 2025)

Historic Enterprise Value for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to -$310.9 million.

  • Agilon Health's Enterprise Value rose 2088.76% to -$310.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$310.9 million, marking a year-over-year increase of 2088.76%. This contributed to the annual value of -$400.0 million for FY2024, which is 1823.39% up from last year.
  • According to the latest figures from Q3 2025, Agilon Health's Enterprise Value is -$310.9 million, which was up 2088.76% from -$327.0 million recorded in Q2 2025.
  • Agilon Health's 5-year Enterprise Value high stood at -$105.4 million for Q1 2021, and its period low was -$1.1 billion during Q2 2021.
  • Moreover, its 5-year median value for Enterprise Value was -$565.0 million (2023), whereas its average is -$643.3 million.
  • Per our database at Business Quant, Agilon Health's Enterprise Value tumbled by 87414.58% in 2021 and then skyrocketed by 4863.28% in 2024.
  • Over the past 5 years, Agilon Health's Enterprise Value (Quarter) stood at -$1.0 billion in 2021, then increased by 15.62% to -$877.8 million in 2022, then soared by 44.28% to -$489.2 million in 2023, then increased by 18.23% to -$400.0 million in 2024, then increased by 22.28% to -$310.9 million in 2025.
  • Its Enterprise Value was -$310.9 million in Q3 2025, compared to -$327.0 million in Q2 2025 and -$367.1 million in Q1 2025.